Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Axogen (AXGN) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Axogen (AXGN) over the last 16 years, with Q3 2025 value amounting to 3.18%.

  • Axogen's EBITDA Margin rose 38300.0% to 3.18% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.84%, marking a year-over-year increase of 65300.0%. This contributed to the annual value of 1.75% for FY2024, which is 117400.0% up from last year.
  • Latest data reveals that Axogen reported EBITDA Margin of 3.18% as of Q3 2025, which was up 38300.0% from 2.95% recorded in Q2 2025.
  • Axogen's EBITDA Margin's 5-year high stood at 4.08% during Q4 2024, with a 5-year trough of 36.51% in Q1 2022.
  • For the 5-year period, Axogen's EBITDA Margin averaged around 12.05%, with its median value being 13.14% (2022).
  • Its EBITDA Margin has fluctuated over the past 5 years, first tumbled by -183100bps in 2021, then soared by 172000bps in 2024.
  • Quarter analysis of 5 years shows Axogen's EBITDA Margin stood at 16.97% in 2021, then rose by 9bps to 15.51% in 2022, then soared by 52bps to 7.44% in 2023, then skyrocketed by 155bps to 4.08% in 2024, then fell by -22bps to 3.18% in 2025.
  • Its EBITDA Margin stands at 3.18% for Q3 2025, versus 2.95% for Q2 2025 and 3.42% for Q1 2025.